The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -71.89%.However, over the last six months, we can see a stronger performance of -75.76%. Over the last 30 days, the price of IOVA has fallen by 18.18%. And in the last five days, it has fallen by -5.88%.
Iovance Biotherapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $12.51 on 11/07/24 and the lowest value was $1.64 on 05/19/25.
52-week price history of IOVA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Iovance Biotherapeutics Inc’s current trading price is -83.37% away from its 52-week high, while its distance from the 52-week low is 26.95%. The stock’s price range during this period has varied between$1.64 and $12.51. The Iovance Biotherapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 7.46 million for the day, a figure considerably lower than their average daily volume of 13.08 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly decline of -44.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 694.58M and boasts a workforce of 838 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
IOVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
